GCM
GRTS

Graham Capital Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Graham Capital Management’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-36,991
Closed -$72.1K – 1346
2023
Q2 		$72.1K Buy
+36,991
New +$86.6K ﹤0.01% 905
2022
Q2 		– Sell
-207,544
Closed -$855K – 1293
2022
Q1 		$855K Buy
+207,544
New +$1.1M 0.03% 367

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Graham Capital Management's GRTS Position: Q3 2023 in Review

Graham Capital Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2023, closing a stake of 36,991 shares — an estimated $72.1K sold.

Graham Capital Management first reported a position in GRTS in Q1 2022 and held it in 2 quarters. The position peaked at $855K in Q1 2022. 89 funds tracked by Wall St. Rank hold GRTS as of Q3 2023.

  • Graham Capital Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Graham Capital Management sold 36,991 Gritstone bio, Inc. Common Stock shares in Q3 2023, an estimated $72.1K.
  • Graham Capital Management first reported a position in Gritstone bio, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Graham Capital Management's Gritstone bio, Inc. Common Stock position peaked at $855K in Q1 2022.
  • 89 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2023.

Based on Graham Capital Management's 13F filing for Q3 2023, filed 22 Nov 2023.